Poly{dl-lactide-b-[oligo(ethylene glycol) methyl ether (meth)acrylate)]} block copolymers. Synthesis, characterization, micellization behavior in aqueous solutions and encapsulation of model hydrophobic compounds
JOURNAL OF POLYMER SCIENCE
Authors: Karanikolopoulos, Nikos; Choinopoulos, Ioannis; Pitsikalis, Marinos
Abstract
A series of well-defined poly{dl -lactide-b-[oligo(ethylene glycol) methyl ether (meth)acrylate)]} (PDLLA-b-POEG[M]A) functional amphiphilic diblock copolymers was synthesized by employing a multistep procedure involving: (a) ring-opening polymerization of dl -lactide using n-decanol and stannous octoate as the initiating system, (b) esterification reaction of the PDLLA hydroxyl end groups with 2-bromoisobutyryl bromide, (c) atom transfer radical polymerization of OEG(M)A with the newly created bromoisobutyryl initiating site, and (d) incorporation of biotin or folic acid at the POEGA chain ends using click chemistry. The products were characterized by NMR spectroscopy and SEC analysis. The aggregation behavior of the synthesized block copolymers was investigated by dynamic light scattering at 25 degrees C in aqueous solutions. The hydrophobic model compounds Nile red and pyrene were efficiently incorporated into the copolymer aggregates in aqueous solutions. High partition coefficient values were determined by fluorescence spectroscopy.
Investigating complement mediated interference in class I HLA-specific antibodies following renal transplantation
TRANSPLANT IMMUNOLOGY
Authors: Goldsmith, Petra; Lowe, David; Wong, Chang; Howse, Matthew; Ridgway, Dan; Hammad, Abdul; Mehra, Sanjay; Christmas, Steve; Gebel, Howard; Bray, Robert; Jones, Andrew
Abstract
Introduction: Single antigen bead testing (SAB) for HLA-specific antibody enables efficient organ allocation and aids in the diagnosis of antibody mediated rejection. In this retrospective cohort study, a population of kidney transplant recipients possessing HLA Class I antibodies was used to evaluate the best method for resolving complement interference, the so called "prozone" effect. The aim was to compare the use of EDTA versus a Biotin-Streptavidin Complex as methodological approaches for abating the prozone effect using a fixed 1 in 10 dilution as validation. Methods: One hundred and seventeen patients transplanted in our centre between 2009 and 2014 were identified as having class I HLA-specific antibody(-ies) using a Labscreen (R) Mixed assay. Positive sera underwent class I HLA-specific SAB testing; for comparison a standard SAB with and without EDTA, BSC and dilution (1 in 10) modifications were utilised. Samples were processed on the Luminex platform generating 11,349 bead reactions for analysis. Results: We identified sera from 23 patients giving rise to 170 bead reactions showing complement interference. Using linear modelling, we observed slightly higher MFIs on average in both EDTA and BSC modifications when compared to the standard assay, allowing the nominal threshold MFI of 2000 in the standard assay to be adjusted to 2097 and 2033 in the EDTA and BSC assays respectively. We calculated 99% prediction intervals to establish outlier bead reactions for each assay. The 1 in 10 dilution was used as a crosscheck for determining which prozone reactions were overcome by EDTA and BSC. Using ROC curve analysis, EDTA was found to be similar to 90% sensitive and 100% specific compared to BSC which was similar to 60% sensitive and 100% specific in ameliorating prozone positive reactions at the thresholds defined by linear models. Discussion: Our data indicates that both EDTA and BSC are suitable assays in overcoming CMI. We recommend that all clinical laboratories adopt a validated assay designed specifically to abrogate CMI for all potential renal transplant recipients, as the standard assay is inhibited in nearly 20% of a post-transplant cohort.